Drug-labels.com

Nasacort Aq: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
55 mcg
Active ingredient:
ATC code:
Similar drugs:

Source: Health Canada – Drug Product Database (DPD) and product monographs · About this document

Patient Medication Information: uses, side effects, how to take - Nasacort Aq

What is NASACORT AQ used for?

NASACORT AQ is used in children (4 to 12 years of age), to treat the symptoms of:

  • Seasonal allergic rhinitis (also called “hay fever”); and
  • Perennial allergic rhinitis (year-round allergies).

How does NASACORT AQ work?

NASACORT AQ belongs to a group of medicines called corticosteroids. NASACORT AQ reduces the irritation and inflammation in the lining of the nose and nasal passages caused by allergies and relieves the blocked up feeling in the nose, runny nose, itching and sneezing.

What are the ingredients in NASACORT AQ?

Medicinal ingredients: Triamcinolone Acetonide

Non-medicinal ingredients: Benzalkonium chloride, carboxymethylcellulose sodium, dextrose, edetate disodium, microcrystalline cellulose, polysorbate 80 and Purified water. Hydrochloric acid or sodium hydroxide may be added to adjust pH.

NASACORT AQ comes in the following dosage forms: Nasal spray: 55 mcg per metered spray

Do not use NASACORT AQ if:

  • You are allergic to any of the ingredients in NASACORT AQ;
  • You have active or dormant tuberculosis;
  • You have an untreated fungal, bacterial and/or viral infection.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take NASACORT AQ. Talk about any health conditions or problems you may have, including if you:

  • Have already taken NASACORT AQ or any other corticosteroids and developed an allergy or intolerance to any of them;
  • Are allergic to any other substances, such as food, preservatives or dyes;
  • Have asthma;
  • Are recovering from recent surgery, trauma or sores to your nose;
  • Have or are recovering from a fungal infection in your nose;
  • Have been exposed to chickenpox or measles. If you think you have been exposed, tell your healthcare professional right away;
  • Have hypothyroidism (a condition where the thyroid isn’t making enough hormone);
  • Have cirrhosis (a damaged liver);
  • Have or had a history of any eye disorders such glaucoma or cataracts;
  • Are taking other corticosteroid medicines by mouth or as an injection

  • Are pregnant or think you are pregnant;

  • Are breastfeeding or planning to breastfeed.

Other warnings you should know about:

Eye problems: Medications like NASACORT AQ can cause eye disorders such as:

  • Glaucoma: An increase in eye pressure, or eye pain. Untreated it may lead to permanent vision loss;
  • Cataracts: clouding of the lens in the eye, blurry vision or eye pain.

If you haven any changes in your vision, tell your healthcare professional right away. You should have regular eye exams. Growth in Children: Slower growth in children using NASACORT AQ can occur. You and your healthcare professional should monitor your child’s growth.

Withdrawal: If you take NASACORT AQ for a prolonged period, do NOT stop taking it without talking to your healthcare professional first. If you stop your treatment abruptly you may experience symptoms of withdrawal such as joint and/or muscle pain, lack of energy, depression, shaking, weight loss, anxiety, nasal drip, bleeding from the nose or the return of symptoms you are trying to treat. If you need to stop taking NASACORT AQ, or have any concerns, talk to your healthcare professional.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with NASACORT AQ:

NASACORT AQ has no known drug interactions.

How to take NASACORT AQ:

  • Before use, read the INSTRUCTIONS FOR USE included.
  • Use exactly as directed, DO NOT use NASACORT AQ more, or more often than your healthcare professional has told you to.

Usual dose:

Children 4 to 12 years of age: The recommended dose is one spray in each nostril once a day.

DO NOT stop using NASACORT AQ even if you feel better, unless your healthcare professional tells you to. It may take a few days for NASACORT AQ to start working. You will get the best results if you keep using NASACORT AQ regularly each day, without missing a dose.

If your symptoms do not improve after three weeks of treatment, talk to your doctor. If your doctor decides to stop treatment, do not keep any leftover medicine unless your doctor tells you to.

Overdose:

If you think you, or a person you are caring for, have taken too much NASACORT AQ, contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If you miss a dose and remember within an hour or so, take the missed dose. However, if you do not remember until later, skip the missed dose and go back to your regular dosing schedule. Do not take double doses.

What are possible side effects from using NASACORT AQ?

These are not all the possible side effects you may have when taking NASACORT AQ. If you experience any side effects not listed here, tell your healthcare professional.

  • Nose bleeds, nasal ulcers, pain, burning, irritation, soreness or dryness inside of the nose
  • Sore throat, flu-like symptoms, fever, bronchitis, cough, stuffy nose
  • Headache
  • Unpleasant taste or smell

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
COMMON
Nasal Infection: yellow/green discharge from nose✓
RARE
Nasal septum perforation: (small holes in the wall between the 2 nostrils): constant whistling sounds when you breathe from your nose.✓
UNKNOWN FREQUENCY
Cataracts: clouding of the lens in the eye, blurry vision, and/or eye pain✓
Glaucoma (increased pressure in your eyes): eye and head pain, swelling or redness in or around the eye, changes in vision, hazy or blurred vision, sudden sight loss✓
Slowed growth in children and adolescents✓

Storage:

Store at 15 - 25°C.

Do not use NASACORT AQ after the expiry date which is stated on the carton and the bottle after “EXP”.

The bottle should be discarded after 120 sprays or 2 months after starting treatment.

Keep out of reach and sight of children.

If you want more information about NASACORT AQ:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html; the manufacturer’s website www.sanofi.ca, or by calling 1-800-636-3664.

Last Revised September 14, 2022

INSTRUCTIONS FOR USE

It is important to shake the bottle gently before each use. The bottle should be discarded after 120 sprays or 2 months after starting treatment. Do not transfer any remaining liquid to another bottle.

PrNASACORT® AQ

(Triamcinolone Acetonide Nasal Spray, USP)

  1. 1.

    IMPORTANT INFORMATION

    a. Read this insert for complete instructions on how to get a bottle ready (primed), how to use the spray bottle and how to clean the spray nozzle.

    b. Keep this insert as it contains important information.

    c. NASACORT AQ is for nasal use only.

    d. Do not use more than directed.

    e. Do not share this bottle with anyone else as this may spread germs.

PrNASACORT® AQ

(Triamcinolone Acetonide Nasal Spray, USP)

  1. 2. STEPS TO GET A NEW BOTTLE READY FOR USE (PRIMED)

A. Before first use, a new bottle must be primed.

a. Remove purple cap (Figure A).

b. Shake the bottle gently before use.

c. Hold the bottle upright. Point the spray away from you or other people while doing this. Press and release spray nozzle until a fine mist is produced, taking care not to spray into eyes or face (as shown in Figure B). If you get the spray in your eyes, rinse well with water.

d. The spray is now ready to use.

B. If NASACORT AQ has not been used for more than 2 weeks, prime the bottle again. Repeat steps “a” through “c” above.
  1. 3.

    USE INSTRUCTIONS

    a. Blow nose gently to clear nostrils.

    b. Remove cap, then shake the bottle gently.

    c. Hold the bottle with thumb under bottle and spray nozzle between your fingers (as shown in Figure B).

    d. Close off one nostril with your finger.

PrNASACORT® AQ

(Triamcinolone Acetonide Nasal Spray, USP)

e. Aim nozzle toward back of nose (Figure C).

DO NOT spray toward nasal septum (the wall between the 2 nostrils) (Figure D).

f. While breathing in gently, press down on the spray nozzle with your fingers to release the spray.

g. Repeat steps “d” through “f” for the other nostril.

h. If you have been prescribed two sprays per nostril, repeat steps “d” through “f” again for both nostrils.

i. After using the nasal spray, wipe nozzle with a tissue and replace cap.

NOTE: Avoid blowing nose for 15 minutes after use.

If nozzle does not spray properly, see cleaning instructions below.

PrNASACORT® AQ

(Triamcinolone Acetonide Nasal Spray, USP)

  1. 4.

    IF PUMP DOES NOT SPRAY PROPERLY,

    THE NOZZLE MAY BE BLOCKED

    • a. Never try to unblock nozzle or enlarge the tiny spray hole with a pin or other sharp objects. This can stop the spray from working. (Figure E).
    • b. Clean the nozzle as shown below.

PrNASACORT® AQ

(Triamcinolone Acetonide Nasal Spray, USP)

  1. 5.

    CLEANING INSTRUCTIONS

    a. Remove the cap.

    b. Gently pull off the spray nozzle away from bottle (Figure F).

    c. Rinse SPRAY NOZZLE ONLY under warm water (Figure G).

    d. Shake or tap to remove any water that is left.

    e. Re-attach spray nozzle to bottle.

    f. Press and release spray nozzle until a fine spray is produced, taking care not to spray in your eyes or face. If you get the spray in your eyes, rinse well with water.

    g. Replace the cap over the nozzle.

    NASACORT AQ is now ready to use.

Below is a check-off chart to help you keep track of the number of sprays you have used. This will help assure that you receive the 120 sprays of medication present. The bottle has been filled with extra solution to accommodate the initial priming sprays. Any additional repriming (i.e. other than the initial priming) must be counted below as a spray.

NASACORT AQ 120 Sprays Check-Off

(Include treatment inhalations and repriming sprays)

Check off one circle for one spray.

The bottle should be discarded after 120 sprays or 2 months after starting treatment.

Do not transfer any remaining liquid to another bottle.

Last revised:

September 14, 2022

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02213834

Revision date stated in the text: September 14, 2022

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Nasacort Aq

Rx or OTC
Prescription (Rx)?
DIN 02213834
Schedule(s) PRESCRIPTION
Active ingredient(s) Triamcinolone acetonide 55 MCG
Dosage form(s) Spray (Metered-Dose)
Route(s) of administration Nasal
Drug class (WHO ATC)
  1. R Respiratory system drugs
    1. R01 Nasal preparations
      1. R01A Decongestants and other nasal preparations for topical use
        1. R01AD Corticosteroid nasal preparations for topical use
          1. R01AD11 Triamcinolone
Company SANOFI CONSUMER HEALTH INC
Current status Marketed
Current status date July 16, 2022

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.